MACQUARIE GROUP LTD
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1418333
Sydney, NSW 2000, C3
Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,865,804
+$898,821 QoQ
Shares Held
37,980
-5.6% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#272
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 37%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACQUARIE GROUP LTD holds $47,158,112 across 21 Biotechnology names. VRTX ranks #1 (40.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
37,980 | $18,865,804 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,532 | $10,931,901 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,943 | $6,304,471 | |
| 4 | INCY |
Incyte Corp
|
33,301 | $3,775,000 | |
| 5 | RPRX |
Royalty Pharma plc
|
41,037 | $2,300,944 | |
| 6 | EXEL |
Exelixis, Inc.
|
27,485 | $1,495,458 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,331 | $623,829 | |
| 8 | INSM |
INSMED Inc
|
5,193 | $553,677 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,865,804 | 37,980 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $17,966,983 | 40,236 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,281,512 | 44,736 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $87,553,469 | 223,556 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $101,885,354 | 228,853 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $113,513,813 | 234,136 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $92,594,018 | 229,933 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $151,856,059 | 326,516 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $157,370,394 | 335,745 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $155,600,459 | 372,241 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $161,654,954 | 397,294 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $254,174,640 | 730,933 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $251,416,819 | 714,435 | Shares | Sole | 2023-10-27 | |
| 2023-03-31 | $241,461,454 | 766,374 | Shares | Sole | 2023-06-01 | |
| 2022-12-31 | $248,148,652 | 859,300 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $259,806,557 | 897,308 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $262,960,509 | 933,179 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $73,295,510 | 280,858 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $66,814,836 | 304,257 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $244,969,914 | 1,350,515 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $325,990,138 | 1,616,774 | Shares | Other | 2021-08-13 | |
| 2021-03-31 | $32,338,150 | 150,487 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $32,166,582 | 136,103 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $35,474,651 | 130,364 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $32,203,216 | 110,927 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $25,965,103 | 109,120 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||